Layer, Chiang, et al. Genome Biology
With New Strategy, Alnylam Again Shuffles Its Pipeline
"As part of our … strategy, we have made portfolio decisions to focus our investments in our highest-value activities and on programs with exciting potential for addressing major unmet medical needs," Alnylam President and COO Barry Greene said in a statement.
New to GenomeWeb? Register here quickly.